Regulation of triacylglycerol and phospholipid trafficking by fatty acids in newborn swine enterocytes.
We (Wang H, Berschneider HM, Du J, and Black DD. Am J Physiol Gastrointest Liver Physiol 272: G935-G942, 1997; Wang H, Lu S, Du J, Yao Y, Berschneider HM, and Black DD. Am J Physiol Gastrointest Liver Physiol 280: G1137-G1144, 2001) previously showed that different fatty acids influence synthesis and secretion of triacylglycerol (TG) and phospholipid (PL) in a newborn swine enterocyte cell line (IPEC-1). The most striking effects were produced by stearic acid (SA; 18:0), which modestly affected TG and PL synthesis but reduced TG and PL secretion, and by eicosapentaenoic acid (EPA; 20:5), which reduced TG and PL synthesis and TG secretion relative to oleic acid (OA; 18:1). To define the mechanism of these effects, differentiated IPEC-1 cells were incubated for 24 h with OA, SA, or EPA and [(3)H]glycerol. Endoplasmic reticulum (ER) and Golgi (G) content of labeled lipids and apolipoprotein (apo) B and apoAI protein were measured. Relative to OA, SA did not impair ER TG synthesis, but reduced movement of labeled TG from ER to G. EPA impaired both ER TG synthesis and movement of labeled TG from ER to G. PL followed the same pattern, except ER synthesis of PL was relatively unaffected by EPA. Carbonate treatment demonstrated decreased partitioning of labeled lipid from ER membrane to lumen in EPA-treated cells. Organelle apoB and apoAI content demonstrated opposite patterns after SA and EPA incubation. We conclude that SA and EPA adversely influence immature enterocyte ER to G lipid trafficking, compared with OA. Furthermore, EPA inhibits ER lipid synthesis and transfer of membrane lipid to luminal particles. Regulation of apoAI ER to G trafficking is independent of that of apoB.
Yao
Ying
Y
Children's Foundation Research Center at Le Bonheur Children's Medical Center, University of Tennessee Health Science Center, Memphis, Tennessee 38103, USA.
Eshun
John K
JK
Lu
Song
S
Berschneider
Helen M
HM
Black
Dennis D
DD
D000818:Animals; D000831:Animals, Newborn; D016632:Apolipoprotein A-I / Q000378:metabolism; D001055:Apolipoproteins B / Q000378:metabolism*; D001095:Arachidonic Acids / Q000494:pharmacology; D002460:Cell Line; D004721:Endoplasmic Reticulum / Q000378:metabolism; D020895:Enterocytes / Q000166:cytology / Q000378:metabolism*; D005227:Fatty Acids / Q000494:pharmacology*; D006056:Golgi Apparatus / Q000378:metabolism; D019301:Oleic Acid / Q000494:pharmacology; D021381:Protein Transport / Q000187:drug effects* / Q000502:physiology; D013229:Stearic Acids / Q000494:pharmacology; D013347:Subcellular Fractions; D013552:Swine; D014280:Triglycerides / Q000493:pharmacokinetics*; D014316:Tritium
D016632:Apolipoprotein A-I; D001055:Apolipoproteins B; D001095:Arachidonic Acids; D005227:Fatty Acids; D013229:Stearic Acids; D014280:Triglycerides; D014316:Tritium; D019301:Oleic Acid; C031183:stearic acid